MedPath
NMPA Approval

Denosumab Injection

S20190025

Amgen Inc.

May 21, 2019

Drug Information

地舒单抗注射液

安加维

安加维

注射剂

120mg/1.7mL/瓶

生物制品

May 21, 2019

May 20, 2024

Company Information

Applicant Company

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320 United States of America

Manufacturing Company

amgen manufacturing limited (aml)

State Road 31, Kilometer 24.6, Juncos, Puerto Rico 00777 United States of America

© Copyright 2025. All Rights Reserved by MedPath
地舒单抗注射液 - NMPA 批准文号 | MedPath